Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 2176 AL 2190

Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease

Sousa NMF, Brucki SMD.

Arq Neuropsiquiatr. 2023 Feb;81(2):155-163. doi: 10.1055/s-0042-1758448. Epub 2023 Mar 2.

Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial

Fernandez HH, Weintraub D, Macklin E, Litvan I, Schwarzschild MA, Eberling J, Videnovic A, Kenney CJ; Parkinson Study Group SYNAPSE Investigators.

Parkinsonism Relat Disord. 2023 Sep;114:105511. doi: 10.1016/j.parkreldis.2023.105511. Epub 2023 Jul 13.

Wrist-worn sensor-based measurements for drug effect detection with small samples in people with Lewy Body Dementia

Chen C, Kowahl NR, Rainaldi E, Burq M, Munsie LM, Battioui C, Wang J, Biglan K, Marks WJ Jr, Kapur R.

Parkinsonism Relat Disord. 2023 Apr;109:105355. doi: 10.1016/j.parkreldis.2023.105355. Epub 2023 Mar 4.

SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses

Smadi M, Kaburis M, Schnapper Y, Reina G, Molero P, Molendijk ML.

Br J Psychiatry. 2023 Aug;223(2):348-361. doi: 10.1192/bjp.2023.43.

Association between animal protein sources and risk of neurodegenerative diseases: a systematic review and dose-response meta-analysis

Talebi S, Asoudeh F, Naeini F, Sadeghi E, Travica N, Mohammadi H.

Nutr Rev. 2023 Aug 10;81(9):1131-1143. doi: 10.1093/nutrit/nuac114.

Global ambient particulate matter pollution and neurodegenerative disorders: a systematic review of literature and meta-analysis

Gong Y, Zhang X, Zhao X, Chang H, Zhang J, Gao Z, Mi Y, Chen Y, Zhang H, Huang C, Yu Z.

Environ Sci Pollut Res Int. 2023 Mar;30(14):39418-39430. doi: 10.1007/s11356-023-25731-0. Epub 2023 Feb 10.

Uric acid levels and their association with vascular dementia and Parkinson's disease dementia: a meta-analysis

Li Q, Cen K, Cui Y, Feng X, Hou X.

Neurol Sci. 2023 Jun;44(6):2017-2024. doi: 10.1007/s10072-023-06620-3. Epub 2023 Jan 24.

New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis

Rahmati M, Yon DK, Lee SW, Soysal P, Koyanagi A, Jacob L, Li Y, Park JM, Kim YW, Shin JI, Smith L.

J Med Virol. 2023 Jul;95(7):e28909. doi: 10.1002/jmv.28909.

Genome-Wide Meta-Analysis of Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Parkinson's Disease Cohorts

Ta M, Blauwendraat C, Antar T, Leonard HL, Singleton AB, Nalls MA, Iwaki H; Alzheimer's Disease Neuroimaging Initiative (ADNI); and the Fox Investigation for New Discovery of Biomarkers.

Mov Disord. 2023 Sep;38(9):1697-1705. doi: 10.1002/mds.29511. Epub 2023 Aug 4.

Association between the LRP1B and APOE loci and the development of Parkinson's disease dementia

Real R, Martinez-Carrasco A, Reynolds RH, Lawton MA, Tan MMX, Shoai M, Corvol JC, Ryten M, Bresner C, Hubbard L, Brice A, Lesage S, Faouzi J, Elbaz A, Artaud F, Williams N, Hu MTM, Ben-Shlomo Y, Grosset DG, Hardy J, Morris HR.

Brain. 2023 May 2;146(5):1873-1887. doi: 10.1093/brain/awac414.

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis

Bittner N, Funk CSM, Schmidt A, Bermpohl F, Brandl EJ, Algharably EEA, Kreutz R, Riemer TG.

Drugs Aging. 2023 Nov;40(11):953-964. doi: 10.1007/s40266-023-01065-x. Epub 2023 Sep 8.

Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients

Fang C, Hernandez P, Liow K, Damiano E, Zetterberg H, Blennow K, Feng D, Chen M, Maccecchini M.

J Prev Alzheimers Dis. 2023;10(1):25-33. doi: 10.14283/jpad.2022.84.

Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis

Corniello C, Dono F, Evangelista G, Consoli S, De Angelis S, Cipollone S, Liviello D, Polito G, Melchiorre S, Russo M, Granzotto A, Anzellotti F, Onofrj M, Thomas A, Sensi SL.

Seizure. 2023 Jul;109:62-67. doi: 10.1016/j.seizure.2023.05.017. Epub 2023 May 21.

Rare causes of dystonia-parkinsonism with cognitive impairment, behavioral abnormalities, and voiceless whispering stereotypies: Describing the long-term evolution of the neurological phenotype in a patient with the PSEN2 Ile149Thr variant

Romito LM, Prioni S, Braccia A, Catania M, Elia AE, Dondi F, Lucchini S, Bertagna F, Piacentini SHMJ, Eleopra R, Di Fede G.

J Neurol Sci. 2023 Nov 15;454:120846. doi: 10.1016/j.jns.2023.120846. Epub 2023 Oct 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias